Filing Flows › OptimizeRx (OPRX) › How it makes money
How OptimizeRx (OPRX) makes money
OptimizeRx (OPRX) made $20.5M of revenue in the second quarter 2026 (Q2 2026), -30% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $20.5M | 100.0% |
| Operating cash flow | $8.6M | 42.0% |
| Free cash flow | $8.6M | 41.8% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $20.5M | -30% |
| Q1 2026 | $19.8M | -10% |
| Q4 2025 | $32.2M | -0.2% |
| Q3 2025 | $26.1M | +22% |
| Q2 2025 | $29.2M | +55% |
| Q1 2025 | $21.9M | +11% |
| Q4 2024 | $32.3M | +14% |
From OptimizeRx's 10-Q filed Aug 13, 2026 (on EDGAR).
Questions
How does OptimizeRx make money?
OptimizeRx (OPRX) made $20.5M of revenue in the second quarter 2026 (Q2 2026), -30% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.